OSTM1
protein-codingosteoclastogenesis associated transmembrane protein 1
Gene summary
This gene encodes a protein that may be involved in the degradation of G proteins via the ubiquitin-dependent proteasome pathway. The encoded protein binds to members of subfamily A of the regulator of the G-protein signaling (RGS) family through an N-terminal leucine-rich region. This protein also has a central RING finger-like domain and E3 ubiquitin ligase activity. This protein is highly conserved from flies to humans. Defects in this gene may cause the autosomal recessive, infantile malignant form of osteopetrosis. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~136.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009817
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0009817
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0010866
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009817
Submitter: ClinGen
*OSTM1* was first reported in relation to autosomal recessive osteoporosis in 2003 (Chalhoub et al., PMID: 12627228). 6 variants (splice site, nonsense, frameshift, missense) that have been reported in at least 9 probands in 7 publications (PMIDs: 12627228, 15108279, 16813530, 17400532, 17922613, 19507210, 23772242) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is reported to be loss-of-function. This gene-disease relationship is also supported by experimental evidence (interaction, biochemical functional, and functional alteration evidence, as well as a mouse model; PMIDs: 12627228, 16525474, 16813530, 18296023). OSTM1 interacts with CLCN7 by co-localizing and assembling into a structure that includes both proteins. CLCN7 has been classified as definitive for both autosomal dominant and autosomal recessive osteopetrosis by the Skeletal Disorders GCEP. Biochemical functional and functional alteration evidence show that OSTM1 is necessary in signaling processes associated with bone development. The mouse model shows that mutant mice have osteoporosis, early lethality, and brain anomalies, just like affected humans. In summary, there is definitive evidence supporting the relationship between *OSTM1* and autosomal recessive osteopetrosis. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Skeletal Disorders GCEP on the meeting date June 10th, 2024 (SOP Version 10).
Inheritance Pattern: AR
Disease ID:MONDO:0009817
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Hematologic; Musculoskeletal; Neurologic; Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: HSCT has been described
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to OSTM1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_014028.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 108 | 2 | 110 | |||
| missense | 1 | 98 | 5 | 2 | 106 | |
| nonsense | 11 | 2 | 13 | |||
| start loss | 1 | 1 | ||||
| frameshift | 8 | 1 | 1 | 10 | ||
| splice donor/acceptor (+/-2bp) | 1 | 2 | 3 | 6 | ||
| Total | 20 | 7 | 102 | 113 | 4 | 246 |
Highest pathogenic variant AF is 0.000010265057
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_054747.2 | 6 | MANE Select | |
| Ensembl | ENSP00000193322.3 | 6 | MANE Select | |
| Ensembl | ENSP00000398556.2 | 5 | Standard | |
| Ensembl | ENSP00000514449.1 | 2 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Stimuli-sensing channels
- Ion channel transport
- Transport of small molecules
Biological Process
- osteoclast differentiation
Cellular Component
- lysosomal membrane
- cytosol
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000193322
- Coding exons
- 6
- Length
- 124446
- Individuals with no LoFs
- 125730
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 6
- Defined
- 125736
- p
- 0.0000239
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.09 | 139 | 180 | 0.771 | 0.00000855 | 2159 |
| Missense (PolyPhen) | 36 | 60.194 | 0.59806 | 727 | ||
| Synonymous | 0.0508 | 72 | 72.5 | 0.992 | 0.00000320 | 647 |
| Loss of Function | 2.33 | 6 | 16.1 | 0.373 | 9.12e-7 | 174 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000035 | 0.000035 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Required for osteoclast and melanocyte maturation and function. {ECO:0000250, ECO:0000269|PubMed:21527911}.;
- Disease
- DISEASE: Osteopetrosis, autosomal recessive 5 (OPTB5) [MIM:259720]: A rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. Osteopetrosis occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. Recessive osteopetrosis commonly manifests in early infancy with macrocephaly, feeding difficulties, evolving blindness and deafness, bone marrow failure, severe anemia, and hepatosplenomegaly. Deafness and blindness are generally thought to represent effects of pressure on nerves. OPTB5 patients manifest primary central nervous system involvement in addition to the classical stigmata of severe bone sclerosis, growth failure, anemia, thrombocytopenia and visual impairment with optic atrophy. {ECO:0000269|PubMed:12627228, ECO:0000269|PubMed:16813530}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.181
Intolerance Scores
- LoFtool
- 0.492
- RVIS EVS
- -0.36
- RVIS percentile EVS
- 28.63
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.734
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |